News
ZOM
0.1253
+4.42%
0.0053
Zomedica Appoints New CFO to Drive Growth
TipRanks · 1d ago
Zomedica appoints Scott Jordan as EVP, finance & CFO
Seeking Alpha · 2d ago
Weekly Report: what happened at ZOM last week (1209-1213)?
Weekly Report · 5d ago
Weekly Report: what happened at ZOM last week (1202-1206)?
Weekly Report · 12/09 09:47
Weekly Report: what happened at ZOM last week (1125-1129)?
Weekly Report · 12/02 09:48
Weekly Report: what happened at ZOM last week (1118-1122)?
Weekly Report · 11/25 09:45
Weekly Report: what happened at ZOM last week (1111-1115)?
Weekly Report · 11/18 09:44
Zomedica Has Launched Its Third Equine-focused Assay-insulin For Equine Plasma-For Truforma In-Clinic Biosensor Testing Platform
Benzinga · 11/14 11:43
Zomedica Positioned for Growth with Strategic Acquisitions and Strong Financial Performance: Buy Recommendation
TipRanks · 11/11 13:26
Zomedica initiated with an Outperform at Noble Capital
TipRanks · 11/11 13:15
Weekly Report: what happened at ZOM last week (1104-1108)?
Weekly Report · 11/11 09:48
Zomedica’s Revenue Up 10% Amid Global Expansion
TipRanks · 11/08 22:09
Zomedica Corp Posts Increased Revenue Amid Loss
TipRanks · 11/08 06:06
Weekly Report: what happened at ZOM last week (1028-1101)?
Weekly Report · 11/04 09:48
Weekly Report: what happened at ZOM last week (1021-1025)?
Weekly Report · 10/28 09:45
Weekly Report: what happened at ZOM last week (1014-1018)?
Weekly Report · 10/21 09:44
Weekly Report: what happened at ZOM last week (1007-1011)?
Weekly Report · 10/14 09:53
Weekly Report: what happened at ZOM last week (0930-1004)?
Weekly Report · 10/07 09:49
Zomedica expands exclusive equine distribution pact with Grovet in Europe
TipRanks · 10/05 07:56
Zomedica announces expansion of equine distribution agreement with Grovet
TipRanks · 10/05 07:54
More
Webull provides a variety of real-time ZOM stock news. You can receive the latest news about Zomedica Corp through multiple platforms. This information may help you make smarter investment decisions.
About ZOM
Zomedica Corp. is a veterinary health company. The Company is engaged in creating products for horses, dogs, and cats by focusing on the unmet needs of clinical veterinarians. The Company's product portfolio includes diagnostics and medical devices that emphasize patient health and practice health. Its Diagnostics segment consists of TRUFORMA, VetGuardian, and TRUVIEW products. Its Therapeutic Devices segment consists of Assisi and PulseVet products. Its TRUFORMA platform comprises point-of-care diagnostic products for disease states in dogs, cats and horses, providing assays for use at the point-of-care that provide reference lab accuracy. Its TRUVIEW platform consists of the TRUVIEW digital cystoscopy instrument providing microscopic images and related pathology services which enable practitioners to receive a pathologist interpretation of the images. The Assisi Loop platform includes a series of products that use targeted pulsed electromagnetic field (tPEMF) therapy.